Solaris Pharma Launches Generic Briviact®️ to Improve Access to Epilepsy Treatment
Solaris Pharma has launched brivaracetam tablets — the generic equivalent of UCB's Briviact® — marking a notable pivot for a company long anchored in...
Nepal Seeks IIT and AIIMS Campuses to Adopt India’s Success Path
In a landmark move to redefine bilateral cooperation, Nepal’s Minister for Foreign Affairs, Shisir Khanal, has formally proposed the establishment of Indian Institute of...
XOCOVA®️ Becomes First-Ever Oral Pill Approved to Prevent COVID-19 After Exposure
A historic milestone in pandemic preparedness arrived this week as the U.S. Food and Drug Administration granted approval to XOCOVA® (ensitrelvir) — the world’s...
West Bengal Becomes 36th State to Implement Ayushman Bharat PM-JAY, Covering 1.43 Crore Families
West Bengal officially joined the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) on Monday, becoming the 36th State/UT to implement India's flagship...
Surat Gets Major Healthcare Boost as PM Modi Inaugurates ₹216 Crore ESIC Hospital
Prime Minister Narendra Modi has officially inaugurated a newly upgraded, state-of-the-art 220-bedded Employees’ State Insurance Corporation (ESIC) Hospital in Surat, Gujarat. The virtual dedication...
Lupin Teams up with Laboratorios ERN to launch Luforbec®️ PMDI in the Spanish Market
Lupin Limited (Lupin) the Mumbai based Indian pharma major on 08th June announced its strategic collaboration with LABORATORIOS ERN S.A. (ERN), a renowned Spanish pharmaceutical company, for the launch of Luforbec® (beclometasone/formoterol) 100/6, a fixed...
